2 results found

Mingwei Liang, Xinxin Zhang, Wenli Wu, Ruijie Yu, Zhiruo Liao, Qianqian Cao, Xiyue Su, Jia lu, Jihua Wang

Background Incorporating immunotherapy effectively remains a priority in therapeutic research of ovarian cancer, making it essential to conduct and report randomized, controlled trials (RCTs) with hig...

BMC Cancer 2026-04-23 rs-9020902
CONSORT statement ovarian cancer immunotherapy reporting quality randomized controlled trial

Faraz Saif, Fakhra Nain Qureshi, Azaz Ahmad, Fakeeda Durrani, Noor Ul Ain Azam, Imad Ullah, Zia Ud Din Ahmed, Asif Riaz Khan

Purpose The neutrophil-to-lymphocyte ratio (NLR) is an emerging biomarker for predicting febrile neutropenia (FN) in cancer patients. This study aimed to evaluate the association between pre-treatment...

Supportive Care in Cancer 2026-04-23 rs-9106686
Neutrophil-to-lymphocyte ratio (NLR) febrile neutropenia breast cancer ovarian cancer
Back to Top
Home
Browse
Submit
About
0.093344s